EUVIMEDEUVIMED entdecken
Crossref

Transient abnormal myelopoiesis requiring advanced neonatal intensive care treatment

Maria Chalia iD, Emilie Seager, Anupama Rao, Simon Hannam

Acta Paediatrica · 2024

DOI: 10.1111/apa.17142 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Paediatrica, 2024. Verfasst von Maria Chalia und 3 weiteren Autor:innen. Beteiligte Einrichtung: Neonatal Intensive Care Unit, Great Ormond Street Hospital for Children, London, UK. Hauptthemen laut MEDLINE: Down Syndrome, Hypertension, Pulmonary, Leukemoid Reaction. Die Arbeit nennt 27 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

Five to thirty percent of neonates with trisomy 21 develop transient abnormal myelopoiesis (TAM) with a high mortality rate. The aim of the study was to identify contributing factors that determine mortality and need for chemotherapy in this patient group.

Methods

Six‐year, single‐centre, retrospective study of neonatal TAM cases requiring admission to intensive care. Data were collected from electronic patient records, laboratory and genetic results. The odds ratio was calculated to assess the likelihood of neonates with certain clinical characteristics having short‐term mortality and needing chemotherapy.

Results

Twenty‐one neonates were studied with a mortality rate of 28%. Neonates requiring inotropic support (OR 19, 95% CI: 0.9–399, p = 0.05) and inhaled nitric oxide (iNO) (OR 13, 95% CI: 1.4–124.3, p = 0.03) were less likely to survive to discharge. Neonates needing mechanical ventilation (OR 14, 95% CI: 1.1–185.5, p = 0.04), or a white cell count >50 × 10 9 /L (OR 27, 95% CI: 1.2–605.7, p = 0.04) were more likely to receive chemotherapy.

Conclusion

A high mortality rate was identified in TAM neonates with symptomatic pulmonary hypertension (PH) needing active treatment strategies, such as inotropes and iNO. The presence of PH should be considered in the clinical management, prognosis and parental counselling.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Down SyndromeHypertension, PulmonaryLeukemoid ReactionInfant, NewbornHumansIntensive Care, NeonatalRetrospective StudiesNitric OxideAdministration, Inhalation

Stichwörter der Autor:innen

Down syndromeGATA‐1 mutationsblastsneonatetransient abnormal myelopoiesistrisomy 21

Substanzen

Nitric Oxide

Autor:innen und Institutionen

  • Neonatal Intensive Care Unit, Great Ormond Street Hospital for Children, London, UK.
  • Department of Paediatric Haematology and Oncology, Great Ormond Street Hospital for Children, London, UK.

ORCID-Profile: Maria Chalia

Zitieren

APA

Chalia, M., Seager, E., Rao, A., & Hannam, S. (2024). Transient abnormal myelopoiesis requiring advanced neonatal intensive care treatment. Acta Paediatrica. https://doi.org/10.1111/apa.17142

Vancouver

Chalia M, Seager E, Rao A, Hannam S. Transient abnormal myelopoiesis requiring advanced neonatal intensive care treatment. Acta Paediatrica. 2024. doi:10.1111/apa.17142

BibTeX
@article{Chalia2024,
  author = {Chalia, Maria and Seager, Emilie and Rao, Anupama and Hannam, Simon},
  title = {Transient abnormal myelopoiesis requiring advanced neonatal intensive care treatment},
  journal = {Acta Paediatrica},
  year = {2024},
  doi = {10.1111/apa.17142}
}
Kostenlos starten →